Today on the Medscape Medical Minute: A company reports encouraging results from a phase 2 trial of a hypertension drug given subcutaneously; experts say patients with long COVID should get the new COVID booster and flu shot; and a study finds that rates of liver cancer vary substantially by race and ethnicity. https://www.medscape.com/viewarticle/989872